Assertio Holdings, Inc. ASRT

Name: ASRT quality scores
Creator: Stocktoria
License: https://stocktoria.com/terms/

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 1997-02-12

Assertio Holdings, Inc. (ASRT) earns a Piotroski F-score of 2/9 (weak financial health), with an Altman Z″ in the distress zone. It does not currently pay a dividend. FY2025 revenue was $118.7M at a -25.6% net margin.

2/9

Piotroski F — financial health

-6.37

Altman Z″ — distress risk · distress

—

Dividend payout · no dividend

$23.50 as of 2026-06-01 · +144.3% 1y

$9.07$23.5052-wk

Price from month-end closes (Yahoo) — for reference, not real-time.

Market cap$152M

Net margin-25.6%

Return on equity-32.3%

Revenue trend · last 7y · down

How it ranks in Manufacturing · percentile among 1906 companies

Piotroski Fstronger than 12%

Net marginstronger than 34%

Return on equitystronger than 37%

Revenue growthstronger than 22%

Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.

Piotroski F breakdown · 2/9 tests passed

Positive return on assets
Positive operating cash flow
Rising ROA
Cash flow exceeds net income
Lower long-term debt
Rising current ratio
No share dilution
Rising gross margin
Rising asset turnover

Altman Z″ components · distress zone

Component	Value
Working capital / assets	0.334
Retained earnings / assets	-2.635
EBIT / assets	-0.081
Equity / liabilities	0.543

Sector peers · similar-size Manufacturing companies

Ticker	Company	Piotroski F	Altman Z″	P / E	Revenue growth
ASRT	Assertio Holdings, Inc.	2/9	-6.37	—	-5%
GYRE	GYRE THERAPEUTICS, INC.	3/9	8.71	71	+10.2%
XNCR	Xencor Inc	3/9	2.23	—	+13.7%
URGN	UroGen Pharma Ltd.	1/9	-15.59	—	+21.4%
LFCR	LIFECORE BIOMEDICAL, INC. \DE\	3/9	-1.75	—	+0.5%
TBPH	Theravance Biopharma, Inc.	6/9	0.96	8.6	+66.9%
ZVRA	ZEVRA THERAPEUTICS, INC.	5/9	-0.84	9	+350.9%

All Manufacturing companies →

FAQ

Is ASRT financially healthy?

Assertio Holdings, Inc.'s Piotroski F-score is 2/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.

Does ASRT pay a dividend?

No, Assertio Holdings, Inc. does not currently pay a dividend.

How profitable is ASRT?

In FY2025, Assertio Holdings, Inc. had a net margin of -25.6% and a return on equity of -32.3%.

Source: SEC EDGAR filings · CIK 0001808665 · US · as of 2025-12-31. facts plus Stocktoria's own computed scores — not investment advice.